{"id":246018,"date":"2012-05-27T15:41:20","date_gmt":"2012-05-27T15:41:20","guid":{"rendered":"http:\/\/www.eugenesis.com\/ges-healthymagination-names-ceo\/"},"modified":"2012-05-27T15:41:20","modified_gmt":"2012-05-27T15:41:20","slug":"ges-healthymagination-names-ceo","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/ges-healthymagination-names-ceo.php","title":{"rendered":"GE&#8217;s Healthymagination names CEO"},"content":{"rendered":"<div><p><span>Courtesy of <a href=\"http:\/\/www.modernhealthcare.com\/article\/20120521\/NEWS\/305219952?AllowView=VW8xUmo5Q21TcWJOb1gzb0tNN3RLZ0h0MWg5SVgra3NZRzROR3l0WWRMVGJVZjhBRWxiNUtpQzMyWmV1NVgwWUpibWo=&amp;utm_source=link-20120521-NEWS-305219952&amp;utm_medium=email&amp;utm_campaign=hits\" target=\"_blank\">Modern Healthcare<\/a>:<\/span><\/p><div><div><span> <a href=\"http:\/\/www.tissuepathology.com\/.a\/6a00e009846ac18833016766aa3b58970b-popup\"><img decoding=\"async\" alt=\"Sue-Siegel.jpg&amp;maxw=300&amp;maxh=200\" src=\"http:\/\/www.eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/fad50_6a00e009846ac18833016766aa3b58970b-320wi\" style=\"padding-left:10px; padding-right: 10px;\"><\/a><a href=\"http:\/\/www.tissuepathology.com\/weblog\/2012\/04\/ge-healthcare-completes-acquisition-of-seqwright-inc-expanding-capabilities-in-fast-growing-molecula.html\" rel=\"autointext\" target=\"_blank\" title=\"GE Healthcare completes acquisition of SeqWright, Inc., expanding capabilities in fast growing molecular diagnostic segment\">GE<\/a> has named <a href=\"http:\/\/www.crunchbase.com\/person\/sue-siegel\" rel=\"crunchbase\" target=\"_blank\" title=\"Sue Siegel\">Sue Siegel<\/a> a corporate vice president and CEO of <a href=\"http:\/\/www.healthymagination.com\" rel=\"homepage\" target=\"_blank\" title=\"healthymagination\">Healthymagination<\/a>, the company's $6 billion initiative to address global healthcare costs and access.<\/span><p><span>Siegel, 52, joined the Fairfield, Conn.-based company from Mohr Davidow Ventures, where she most recently served as a general partner, according to a&nbsp;<a href=\"http:\/\/www.businesswire.com\/news\/home\/20120521005144\/en\/Sue-Siegel-Lead-Healthymagination\">GE news release<\/a>. She has also held senior positions with <a href=\"http:\/\/www.google.com\/finance?q=NASDAQ:AFFX\" rel=\"googlefinance\" target=\"_blank\" title=\"NASDAQ: AFFX\">Affymetrix<\/a>, a Santa Clara, Calif.-based provider of genomic analysis tools, and reagents vendor Amersham International, which was acquired by GE Healthcare in 2003. <\/span><\/p><\/div><p><\/p><div><span>Siegel replaces Mike Barber, who has been named vice president and general manager of molecular imaging at GE Healthcare. GE launched Healthymagination in May 2009.&nbsp;<\/span><p><span>In her new role, Siegel will oversee quality- and engagement-related initiatives including an innovation challenge focused on early-stage breast cancer and workplace and community health programs.<\/span><\/p><\/div><\/div><p><span><a href=\"\/\/www.modernhealthcare.com\/article\/20120521\/NEWS\/305219952#ixzz1vZ0c5xDA%20%20?trk=tynt\" target=\"_blank\">Read more&nbsp;<\/a><\/span><\/p><p><span>By&nbsp;<a href=\"mailto:jlee@modernhealthcare.com\">Jaimy Lee<\/a><\/span><\/p><div><span>Posted: May 21, 2012 - 3:30 pm ET<\/span><\/div><div><span>Tags:&nbsp;<a href=\"http:\/\/www.modernhealthcare.com\/section\/articles?tagID=70\">Costs<\/a>,&nbsp;<a href=\"http:\/\/www.modernhealthcare.com\/section\/articles?tagID=29\">Executives<\/a>,&nbsp;<a href=\"http:\/\/www.modernhealthcare.com\/section\/articles?tagID=66\">Information Technology<\/a>,&nbsp;<a href=\"http:\/\/www.modernhealthcare.com\/section\/articles?tagID=950\">Vendors<\/a><\/span><\/div><p>&nbsp;<\/p><\/div><div><a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=xSii0eySSXU:Byoh4X1WPc0:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/www.eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/fad50_DigitalPathologyBlog?d=yIl2AUoC8zA\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=xSii0eySSXU:Byoh4X1WPc0:F7zBnMyn0Lo\"><img decoding=\"async\" src=\"http:\/\/www.eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/fad50_DigitalPathologyBlog?i=xSii0eySSXU:Byoh4X1WPc0:F7zBnMyn0Lo\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=xSii0eySSXU:Byoh4X1WPc0:7Q72WNTAKBA\"><img decoding=\"async\" src=\"http:\/\/www.eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/fad50_DigitalPathologyBlog?d=7Q72WNTAKBA\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=xSii0eySSXU:Byoh4X1WPc0:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/www.eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/7a2d5_DigitalPathologyBlog?i=xSii0eySSXU:Byoh4X1WPc0:V_sGLiPBpWU\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=xSii0eySSXU:Byoh4X1WPc0:qj6IDK7rITs\"><img decoding=\"async\" src=\"http:\/\/www.eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/7a2d5_DigitalPathologyBlog?d=qj6IDK7rITs\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=xSii0eySSXU:Byoh4X1WPc0:l6gmwiTKsz0\"><img decoding=\"async\" src=\"http:\/\/www.eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/7a2d5_DigitalPathologyBlog?d=l6gmwiTKsz0\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=xSii0eySSXU:Byoh4X1WPc0:gIN9vFwOqvQ\"><img decoding=\"async\" src=\"http:\/\/www.eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/7a2d5_DigitalPathologyBlog?i=xSii0eySSXU:Byoh4X1WPc0:gIN9vFwOqvQ\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=xSii0eySSXU:Byoh4X1WPc0:TzevzKxY174\"><img decoding=\"async\" src=\"http:\/\/www.eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/7a2d5_DigitalPathologyBlog?d=TzevzKxY174\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a><\/div><p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/www.eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/7a2d5_xSii0eySSXU\" height=\"1\" width=\"1\" style=\"padding-left:10px; padding-right: 10px;\">Source:<br><a href=\"http:\/\/feeds.feedburner.com\/DigitalPathologyBlog\">http:\/\/feeds.feedburner.com\/DigitalPathologyBlog<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Courtesy of Modern Healthcare: GE has named Sue Siegel a corporate vice president and CEO of Healthymagination, the company's $6 billion initiative to address global healthcare costs and access.Siegel, 52, joined the Fairfield, Conn.-based company from Mohr Davidow Ventures, where &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/ges-healthymagination-names-ceo.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577487],"tags":[],"class_list":["post-246018","post","type-post","status-publish","format-standard","hentry","category-pathology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/246018"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=246018"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/246018\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=246018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=246018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=246018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}